Domenico Angellotti

Are you performing right cath after TTVR? EJHF: First insights into the impact of TR elimination on right heart: Immediate RAP reduction ⬇️ Increased systolic RV/PA pressure⬆️ and PAPi ⬆️ Data From Bern by Fabien Praz 🔗 doi.org/10.1002/ejhf.3… @EJHFEiC #CardioTwitter

📊 Real-world data on TTVR unveiled today at #NYValves2025 and simultaneously published in JACC: Cardiovascular Interventions. jacc.org/doi/10.1016/j.… #CardioResearch

#NYValves2025 brings together leaders in SHD: interventionalists, imagers, surgeons, & HF specialists. 📚 Browse new #JACCJournals research published to coincide w/ meeting presentations here: jacc.org/events/confere… #JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports

Non-coaxial transcatheter aortic valve deployment relative to the native annulus is associated with impaired valve early safety and increased risk of bioprosthetic valve failure 1 year after TAVR. jacc.org/doi/10.1016/j.…

1. #EAPCI @escardio Summit in Napoli 🇮🇹 #brainstorming with ESC National Societies & WG on #Education 🌸Day 1️⃣ ⭐️Research ⭐️Scientific Documents ⭐️Certification ⭐️Congress & Sessions at NS #EAPCIfamily

Access free for 50 days our SOTA bit.ly/43gXiwU The Last Decade in Tricuspid Regurgitation: How Imaging Shaped a Field @lpbadano @denisamuraru @FabienPraz @NAjmoneMarsan @VDelgadoGarcia @j_hausleiter @JACCJournals @escardio @ACCinTouch

Just published in @JACCJournals : Severe trans- & para-valvular MR post-healed endocarditis managed with closure of mitral annulus cavity with a nitinol occluder then Tendyne mitral valve implantation It won best case at #PCRLV 2024. @FabienPraz @DomAngellotti @SelimMosbahi…

ELASTA-Clip followed by transapical TMVR is a less invasive Tx for patients with failed M-TEER, with encouraging early results in carefully selected Pts. Preventing PVL and stroke is crucial. Larger, long-term studies are needed @JACCJournals jacc.org/doi/10.1016/j.…

🔴Transcatheter Tricuspid Valve Replacement ⤵️ JACC State-of-the-Art #2025Review #OpenAccess 🔹sciencedirect.com/science/articl… #POCUS #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX

🧵(1/13) Hot off the press: This week, #JACC published a special issue dedicated to the science and evidence behind new advances in tricuspid valve interventions. Follow along for trial deep dives, new Masterclass videos, and more 👇 @hmkyale @crfheart @MartyBLeon #vhdTR

Very happy to see the 1-year results of the PARTHENOPE trial. Can’t wait for the the final 2-year results on a personalized (3-, 6, or 24-m) vs. standard DAPT (12-m) later this year! @EuroInterventio @PCRonline @TCTMD @SCAI @ACCinTouch @SCAI @CircAHA @ESC_Journals #Cardiology

Echo screening of TB patients facilitates early detection of CV involvement. Routine echo at baseline in all newly diagnosed TB patients may allow for timely medical management and prevent complications such as constriction and heart failure. @JACCJournals sciencedirect.com/science/articl…

🔴 Transcatheter Tricuspid Valve Replacement @JACCJournals #Cardioed #Cardiology #CardioTwitter

A moving tribute at #PCRLV to Alex Vahanian who pioneered the concept and philosophy of the #heartteam. In the words of @FabienPraz : a mentor , educator, who always puts his patients first. And above all: a friend. Thank you, Alec!

Fibrotic versus calcific aortic stenosis in patients undergoing TAVR. authors.elsevier.com/a/1k83T6uPJvuW… @AMaznyczka @DomAngellotti @DaijiroTomii @chrisgraeni @DaryoushSamim @pbaekke @StefanStortecky

🎙️ ASK YOUR QUESTION to the #EAPCIJournalClub Team in comments to this post 👇 ‼️Top 3 questions will be asked first in the #EAPCIJournalClub‼️ 📚 Tri.Fr trial 🗓️15 November 2024 ⏰18:00 - 19:00 🔗#ESC365Website Register for FREE: 🔗…

The inflammatory pathway offers a potential therapeutic target in patients undergoing TAVR: in the Co-STAR trial treatment with colchicine was associated with a lower risk of cardiac arrhythmias and subclinical leaflet thrombosis at 30 days. #TCT2024

When it comes to transfemoral access for TAVR it is all about diameter, calcification and tortuosity. In the Bern TAVI registry, the Hostile score proved useful in predicting non-puncture site vascular complications after TAVR. authors.elsevier.com/sd/article/S19…

Looking forward to co-chair this session! @purviparwani @onco_cardiology @EdwinHoMD @AkhilNarangMD @nishath_quader @HamidNadira